A brief online tool to increase behavioral weight loss treatment initiation: Protocol for a cluster randomized trial

IF 1.9 3区医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Contemporary clinical trials Pub Date : 2025-05-15 DOI:10.1016/j.cct.2025.107948

Megan A. McVay , Wendy S. Moore , Dieulerne Deceus , Savannah B. Townsend , Eric I. Rosenberg , Sofia Muenyi , XiangYang Lou , Fern J. Webb , Luis D. Diaz , Meena N. Shankar , Jaime Ruiz , Corrine I. Voils , Kathryn M. Ross

{"title":"A brief online tool to increase behavioral weight loss treatment initiation: Protocol for a cluster randomized trial","authors":"Megan A. McVay , Wendy S. Moore , Dieulerne Deceus , Savannah B. Townsend , Eric I. Rosenberg , Sofia Muenyi , XiangYang Lou , Fern J. Webb , Luis D. Diaz , Meena N. Shankar , Jaime Ruiz , Corrine I. Voils , Kathryn M. Ross","doi":"10.1016/j.cct.2025.107948","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Comprehensive behavioral weight loss treatments are the first-line approach for obesity in adults. However, only a small portion of eligible individuals will initiate treatment, even when available at low or no cost. To address low uptake, we developed the MyHealthPath Tool, a single-session, online, interactive tool designed to be completed prior to a primary care appointment. MyHealthPath Tool includes questions and automated personalized feedback to increase motivation to initiate a behavioral weight loss treatment.</div></div><div><h3>Method/Design</h3><div>In this cluster randomized controlled trial, primary care practitioners (PCPs; target <em>N</em> = 36) are being recruited from primary care clinics across multiple sites of a single academic-affiliated health care system, then randomized to the MyHealthPath Tool or Control condition. Patients (target <em>N</em> = 828) who have upcoming appointments with enrolled PCPs are recruited prior to their PCP appointment. Patients in both conditions are given information about and free access to two behavioral weight loss treatments. Participants in the MyHealthPath Tool condition also receive the tailored interactive tool and the option to share a summary of their responses with their PCP prior to their appointment. The primary outcome is the initiation of behavioral weight loss treatment within 2 months of the patient's PCP appointment. Secondary outcomes include treatment attendance and weight change over 6 months. Implementation-related outcomes (e.g., indicators of reach) are also being measured.</div></div><div><h3>Conclusion</h3><div>If effective, MyHealthPath could serve as a low-touch method for improving uptake of behavioral weight loss treatment in adults receiving primary care.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"154 ","pages":"Article 107948"},"PeriodicalIF":1.9000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425001429","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Comprehensive behavioral weight loss treatments are the first-line approach for obesity in adults. However, only a small portion of eligible individuals will initiate treatment, even when available at low or no cost. To address low uptake, we developed the MyHealthPath Tool, a single-session, online, interactive tool designed to be completed prior to a primary care appointment. MyHealthPath Tool includes questions and automated personalized feedback to increase motivation to initiate a behavioral weight loss treatment.

Method/Design

In this cluster randomized controlled trial, primary care practitioners (PCPs; target N = 36) are being recruited from primary care clinics across multiple sites of a single academic-affiliated health care system, then randomized to the MyHealthPath Tool or Control condition. Patients (target N = 828) who have upcoming appointments with enrolled PCPs are recruited prior to their PCP appointment. Patients in both conditions are given information about and free access to two behavioral weight loss treatments. Participants in the MyHealthPath Tool condition also receive the tailored interactive tool and the option to share a summary of their responses with their PCP prior to their appointment. The primary outcome is the initiation of behavioral weight loss treatment within 2 months of the patient's PCP appointment. Secondary outcomes include treatment attendance and weight change over 6 months. Implementation-related outcomes (e.g., indicators of reach) are also being measured.

Conclusion

If effective, MyHealthPath could serve as a low-touch method for improving uptake of behavioral weight loss treatment in adults receiving primary care.

查看原文本刊更多论文

一个简短的在线工具，以增加行为减肥治疗的启动：一个集群随机试验方案。

背景：综合行为减肥治疗是治疗成人肥胖的一线方法。然而，只有一小部分符合条件的人会开始治疗，即使是在低成本或免费的情况下。为了解决使用率低的问题，我们开发了MyHealthPath工具，这是一个单次在线互动工具，设计用于在初级保健预约之前完成。MyHealthPath工具包括问题和自动的个性化反馈，以增加开始行为减肥治疗的动力。方法/设计：在这组随机对照试验中，初级保健医生(pcp；目标N = 36)是从一个学术附属卫生保健系统的多个站点的初级保健诊所招募的，然后随机分配到MyHealthPath工具或对照条件。即将与已登记的PCP预约的患者（目标N = 828）在其PCP预约之前被招募。在这两种情况下，患者都获得了两种行为减肥治疗的信息和免费机会。MyHealthPath工具条件下的参与者也会收到定制的互动工具，并选择在预约之前与他们的PCP分享他们的回答摘要。主要结果是在患者PCP预约后2 个月内开始行为减肥治疗。次要结局包括6 个月内的治疗出勤率和体重变化。与实施有关的结果（例如，覆盖面指标）也正在被衡量。结论：如果有效，MyHealthPath可以作为一种低接触方法，提高接受初级保健的成年人对行为减肥治疗的接受程度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Contemporary clinical trials 医学-药学

CiteScore

3.70

自引率

4.50%

发文量

281

审稿时长

44 days

期刊介绍： Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.